Generic Musculoskeletal Disorders Drugs Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Generic Musculoskeletal Disorders Drugs Market Growth in 2025?
In the past several years, the global market for generic drugs utilized to treat musculoskeletal disorders has experienced significant growth. The size of this market, estimated to be $0.06 billion in 2024, is predicted to maintain a value of $0.06 billion in 2025 with a compound annual growth rate (CAGR) of 6.7%. The expansion during the historical timeframe can be credited to factors such as a rise in the occurrence of musculoskeletal disorders, changes in regulatory policies, the development of healthcare infrastructure, heightened patient knowledge and education, as well as various economic factors.
What Is the Forecast for the Generic Musculoskeletal Disorders Drugs Market Size Through 2029?
The projected size of the generic musculoskeletal disorder drug market is set for substantial expansion in the coming years, reaching an estimated worth of $0.08 billion by 2029 with a 7.2% compound annual growth rate (CAGR). Factors contributing to this forecasted growth include population increase and aging, emerging market opportunities, precision and personalized medical therapies, healthcare overhaul, and worldwide health tendencies. Major trends expected during the forecast period encompass technological incorporation in treatment methods, government measures and health policies, emphasis on alternative pain management strategies, a heightened uptake of biosimilars, and advances in the development of generic drugs.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp
What are the Key Market Players in Generic Musculoskeletal Disorders Drugs Market and How They’re Evolving?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.
What Are the Primary Growth Drivers in the Generic Musculoskeletal Disorders Drugs Market?
The elevated incidences of arthritis are believed to be a primary factor driving the expansion of the generic musculoskeletal disorders drugs market. Arthritis is characterized by joint swelling and tenderness, which are accompanied by symptoms like joint pain and stiffness. Generic medications for musculoskeletal disorders are used to alleviate muscle pain and stiffness and to treat muscle spasms in individuals suffering from arthritis. As an illustration, in March 2022, data released by Versus Arthritis, a UK-based charity, stated that around 10 million people in the UK are suffering from osteoarthritis. This includes 5.4 million with knee OA and 3.2 million with hip OA, while about 450,000 have rheumatoid arthritis and 190,000 have psoriatic arthritis. This totals to over 20 million individuals grappling with musculoskeletal conditions. This, in turn, led to the dispensation of over 30 million prescriptions for these conditions in 2022-2023, costing approximately £139 million. Consequently, the increased frequency of arthritis is contributing to the expansion of the generic musculoskeletal disorders drugs market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9433&type=smp
What Are the Leading Segments in the Global Generic Musculoskeletal Disorders Drugs Industry?
The generic musculoskeletal disorders drugs market covered in this report is segmented –
1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices
What Are the Key Market Trends in the Generic Musculoskeletal Disorders Drugs Industry?
Strategic alliances are becoming a prevalent trend in the generic musculoskeletal disorders drugs market. Numerous companies in this market are engaging in partnerships to solidify their market positions. For example, Mitsubishi Tanabe Pharma Corporation, a pharmaceutical company based in Japan, formed a partnership with Eli Lilly and Company, a pharmaceutical company from the US, in July 2022. This collaboration allows both companies to expand their product offerings and provide efficient treatments for diseases such as diabetes and other health conditions. Moreover, in February 2022, Pfizer Inc., a U.S. pharmaceutical and biotechnology company, entered into a partnership with Alex Therapeutics, a digital therapeutics company from Sweden. This strategic business alliance offers patients access to evidence-based, clinically validated and bespoke digital therapeutics.
Access The Full Report Here:
What Is the Regional Outlook for the Generic Musculoskeletal Disorders Drugs Market?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9433
This Report Delivers Insight On:
1. How big is the generic musculoskeletal disorders drugs market, and how is it changing globally?
2. Who are the major companies in the generic musculoskeletal disorders drugs market, and how are they performing?
3. What are the key opportunities and risks in the generic musculoskeletal disorders drugs market right now?
4. Which products or customer segments are growing the most in the generic musculoskeletal disorders drugs market?
5. What factors are helping or slowing down the growth of the generic musculoskeletal disorders drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
